Signatures of defective DNA repair and replication in early-onset renal cancer patients referred for germline genetic testing

Elena V. Demidova, Ilya G. Serebriiskii, Ramilia Vlasenkova, Simon Kelow, Mark D. Andrake, Tiffiney R. Hartman, Tatiana Kent, Richard T. Pomerantz, Roland L. Dunbrack Jr., Erica A. Golemis, Michael J. Hall, David Y.T. Chen, Mary B. Daly, Sanjeevani Arora
doi: https://doi.org/10.1101/2022.05.23.22275227

Article Information

doi 
https://doi.org/10.1101/2022.05.23.22275227
History 
  • May 25, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Elena V. Demidova1,2,
  2. Ilya G. Serebriiskii2,3,
  3. Ramilia Vlasenkova2,
  4. Simon Kelow4,
  5. Mark D. Andrake3,
  6. Tiffiney R. Hartman1,5,
  7. Tatiana Kent6,
  8. Richard T. Pomerantz6,
  9. Roland L. Dunbrack Jr.3,
  10. Erica A. Golemis3,7,
  11. Michael J. Hall1,8,
  12. David Y.T. Chen9,
  13. Mary B. Daly*,1,8 and
  14. Sanjeevani Arora*,1,10
  1. 1Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia PA, 19111
  2. 2Kazan Federal University, Russia, 420008
  3. 3Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia PA, 19111
  4. 4Department of Biochemistry and Molecular Biophysics, University of Pennsylvania, Philadelphia, PA,19104
  5. 5Arcadia University, Glenside, PA
  6. 6Department of Biochemistry & Molecular Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107
  7. 7Department of Cancer and Cellular Biology, Lewis Katz School of Medicine, Philadelphia, PA 19140
  8. 8Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia PA, 19111
  9. 9Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia PA, 19111
  10. 10Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia PA, 19111
  1. ↵*Correspondence: Sanjeevani Arora
    , Ph.D., Cancer Prevention and Control Program, Fox Chase Cancer Center, 333 Cottman Avenue, P2149, Philadelphia, PA 19111-2497, Email: Sanjeevani.Arora{at}fccc.edu OR Mary B. Daly
    , M.D., Ph.D., F.A.C.P., Professor, Department of Clinical Genetics, Director, Risk Assessment Program, Timothy R. Talbot Jr. Chair in Cancer Research, Cancer Prevention and Control Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111-2497, Email: Mary.Daly{at}fccc.edu

  1. Author contributions. E.V.D. performed most studies, data analysis and interpretation, figure and table generation, writing & editing; T.R.H., I.G.S. data analysis, discussion; R.V. TCGA analysis; S.K. & M.A. & R.L.D. structure modelling, discussion; T.K., R.T.P. Pol delta purification & methods; E.A.G. discussion; M.J.H. & D.Y.T.C. & M.B.D. patients, discussion; M.B.D. & S.A., discussion, designing, planning studies, writing & editing.

Back to top
Posted May 25, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Signatures of defective DNA repair and replication in early-onset renal cancer patients referred for germline genetic testing
Elena V. Demidova, Ilya G. Serebriiskii, Ramilia Vlasenkova, Simon Kelow, Mark D. Andrake, Tiffiney R. Hartman, Tatiana Kent, Richard T. Pomerantz, Roland L. Dunbrack Jr., Erica A. Golemis, Michael J. Hall, David Y.T. Chen, Mary B. Daly, Sanjeevani Arora
medRxiv 2022.05.23.22275227; doi: https://doi.org/10.1101/2022.05.23.22275227
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area